Moxifloxacin Hydrochloride/Prednisolone Acetate

盐酸莫西沙星/醋酸泼尼松龙

Report date: 2022/01/14 13:23:58

Base Information

Drug NameMoxifloxacin Hydrochloride/Prednisolone Acetate
Drug Alias NamePrednisolone Acetate+Moxifloxacin Hydrochloride醋酸泼尼松龙+盐酸莫西沙星盐酸莫西沙星+醋酸泼尼松龙Prednisolone Acetate/Moxifloxacin HydrochlorideMoxifloxacin Hydrochloride+Prednisolone Acetate +[7] 
ClassificationSmall molecules > Steroids
Mechanisms of ActionBacterial DNA gyrase inhibitorsTopoisomerase IV inhibitorsGlucocorticoid receptor agonists
TargetsGlucocorticoid receptorTopoisomerase IVBacterial DNA gyrase
Therapy Area/IndicationsEye Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes Moxifloxacin HydrochloridePrednisolone Acetate
Global Highest StatusPending (Clinical)
Highest Status in ChinaN/A
Originator CompaniesImprimis Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesImprimis Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsEye Diseases

Other Information

ATC CodeN/A
Related LinksN/A